Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

319.41
-1.5550-0.48%
Volume:106.57K
Turnover:33.99M
Market Cap:19.22B
PE:34.68
High:319.80
Open:319.30
Low:317.21
Close:320.96
52wk High:330.75
52wk Low:249.57
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.46
T/O Rate:0.18%
Dividend:4.72
Dividend Rate:1.48%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.97
PE(LYR):7.69

Loading ...

Merck price target raised to $166 from $141 at BofA

TIPRANKS
·
Aug 20

Merck & Co Inc : RBC Cuts to Sector Perform from Outperform; Raises Target Price to $150 from $142

THOMSON REUTERS
·
Aug 20

Morgan Stanley Upgrades Merck & Co. to Overweight From Equalweight, Adjusts PT to $179 From $116

MT Newswires Live
·
Aug 20

China, Hong Kong Stocks Rise on Healthcare, Tech Advance

Reuters
·
Aug 20

Health Care Roundup: Market Talk

Dow Jones
·
Aug 20

Guotai Asset Management Sees Liquidity Boost Driving China Biotech, Innovation Drug Shares Higher

Reuters
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20

Gubra H1 FY26 Operating Loss Widens to DKK 122.9 Million; Revenue Drops 95% to DKK 126.3 Million

Reuters
·
Aug 20

Merck & Co Inc : Jefferies Raises Target Price to $175 from $152

THOMSON REUTERS
·
Aug 20

Will Foundayo’s UK GLP‑1 Approval and New R&D Deals Change Eli Lilly's (LLY) Narrative?

Simply Wall St.
·
Aug 20

Today’s Market Recap:U.S. Treasury Steps In to Stabilize Markets,Stocks Rally, Bitcoin Breaks $70,000, Moderna Surges 180%

TradingKey
·
Aug 20

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 20

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 20

Merck & Co. Inc. Stock Advances 12.6%, Outperforms Peers

Dow Jones
·
Aug 20

Merck upgraded to Overweight from Equal Weight at Morgan Stanley

TIPRANKS
·
Aug 20

Moderna's Cancer-Vaccine Breakthrough Drives Broad Biopharma Stock Rally

Dow Jones
·
Aug 20

Moderna Shares More than Double on Success of mRNA Cancer Vaccine

Dow Jones
·
Aug 20

Amplitude Therapeutics: Lilly to GET Exclusive, Target-Specific Rights to Develop ,Commercialize Licensed Products Directed to Collaboration Targets

THOMSON REUTERS
·
Aug 20

Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying Rna Vaccines for Infectious Diseases

THOMSON REUTERS
·
Aug 20

Amplitude: Initial Programs Target Infectious Diseases with High Unmet Need, with Lilly Retaining Options for up to Two Additional Targets

THOMSON REUTERS
·
Aug 20